NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.
Don't have an account? Register
ADVERTISEMENT
ADVERTISEMENT
The use of a novel agent, sacituzumab govitecan, an antibody-drug conjugate, resulted...
As we all know, the development of artificial intelligence (AI) has been one of the fastest-growing...
Ibrutinib combined with bendamustine-rituximab improved PFS by 50 per cent for older patients with newly-diagnosed mantle...
The IBTS is working on the introduction of individual risk assessment for blood donors.
The use of panitumumab plus mFOLFOX6 significantly improved OS in patients with RAS wild-type...
Staff at the Department of Health are presently required to work from its office in Dublin...
The use of autologous stem cell transplant (ASCT) early in the course of treatment showed a...
The HSE has no plans to change its staff policy on WhatsApp usage, which was introduced...
The addition of nimotuzumab to gemcitabine increases OS in patients with KRAS wild-type advanced...
New research has provided important insight into what drives metastases in prostate cancer...
The outgoing President of the ICGP, Prof Tom O’Dowd, has said that a forthcoming report from...
Malignant melanoma, the most serious type of skin cancer, is the fifth most commonly...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT